Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
US Stock Insider Trading | United Treatment disclosed 1 insider trading transaction on March 2
On March 2, 2026, United Therapeutics (UTHR) disclosed one insider transaction. Director Olian Judy D. sold 200 shares on February 27, 2026.
【Recent Insider Transactions】
【Company Profile】
United Therapeutics Corporation was founded in Delaware in 1996. It is a biotechnology company dedicated to developing and commercializing unique products that address unmet medical needs for patients with chronic and life-threatening conditions. Its revenue mainly comes from sales of Remodulin, Tyvaso, and Tadalafil. Their marketing and sales teams work hard to make their products available in authorized countries, primarily through their professional distributors in the U.S. and other international distributors.